Bioavailability, Bioequivalence and Clinical Trials Project
Clinical Pharmacology Unit & Bioanalytical Laboratory for BA/BE Studies and Phase I–III Clinical Trials
Project Overview
It consisted of a 100-bed dedicated in-house facility for healthy volunteers and patients. The organization maintained a database of more than 500 healthy volunteers, enabling rapid recruitment and execution of BA/BE studies. Approximately 200 BA/BE studies were successfully completed along with several Phase II and Phase III clinical studies, including a large Insulin Clinical Trial involving 132 subjects.
The facility operated under approvals and inspections from DCGI (India), USFDA, UK MHRA, ANVISA (Brazil), WHO-GMP, and European regulatory agencies, demonstrating compliance with Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and international regulatory requirements. Bioanalytical laboratories in CROs routinely use validated LC-MS/MS methods to quantify drugs in biological samples for pharmacokinetic and bioequivalence assessments.
Product / Study Process
Unlike pharmaceutical manufacturing plants, it does not manufacture drug products. Instead, it evaluates the safety, efficacy, pharmacokinetics, and bioequivalence of pharmaceutical formulations. The overall study process consisted of:
Receipt of Investigational Product
Investigational product and reference product are received from the sponsor.
Study Protocol Preparation
Study protocol is prepared and approved.
Ethics Committee Approval
Study is reviewed and approved by the Ethics Committee.
Regulatory Approval
Approval is obtained from DCGI and other authorities.
Volunteer Recruitment
Volunteers are recruited and informed consent is obtained.
Medical Screening
Volunteers undergo medical screening.
Subject Admission
Subjects are admitted into the Clinical Pharmacology Unit.
Controlled Dosing
Dosing is carried out under physician supervision.
Blood Sample Collection
Samples are collected according to the pharmacokinetic sampling schedule.
Plasma Separation & Storage
Plasma is separated and stored at controlled temperatures.
Bioanalytical Analysis
Analysis is performed using validated LC-MS/MS methods.
Pharmacokinetic Evaluation
Pharmacokinetic parameters are evaluated.
Statistical Comparison
Test and Reference formulations are statistically compared.
Clinical Study Report
The Clinical Study Report is prepared.
Regulatory Submission
Study data is submitted to regulatory authorities.
The scientific objective was to demonstrate that the generic formulation exhibited equivalent bioavailability compared with the innovator product while ensuring volunteer safety and regulatory compliance.
Critical Equipment
Major equipment installed included:
Clinical Pharmacology Unit
- 100 Patient Beds
- ICU & Emergency Equipment
- Cardiac Monitors
- Multiparameter Monitors
- ECG Machines
- Defibrillators
- Infusion Pumps
- Oxygen Supply
- Emergency Crash Carts
- Refrigerators for Investigational Products
Bioanalytical Laboratory
- LC-MS/MS Systems – 10 Nos
- HPLC Systems – 12 Nos
- Refrigerated Centrifuges
- Deep Freezers (−20°C and −70°C)
- Plasma Storage Freezers
- Analytical Balances
- Water Purification Systems
- Nitrogen Generators
- Vacuum Concentrators
- Laboratory Information Management System (LIMS)
LC-MS/MS instruments formed the backbone of the laboratory because they provide highly sensitive and selective quantification of drugs and metabolites in plasma samples required for pharmacokinetic analysis.
Utilities
Continuous and reliable utilities were essential for uninterrupted clinical and laboratory operations. Major utilities included:
- HVAC Systems Maintaining Controlled Environmental Conditions
- Clean Water Generated Through Purified Water Systems
- Medical Oxygen
- Compressed Air
- Nitrogen Gas for LC-MS/MS
- UPS Power Backup
- Diesel Generator Sets
- Biomedical Waste Treatment
- Fire Detection & Fire Protection Systems
- Cold Storage Facilities (−20°C and −70°C)
- CCTV Surveillance
- Access Control Systems
Temperature mapping and continuous monitoring ensured integrity of biological samples and investigational medicinal products throughout storage and analysis.
Laboratory Testing
The Bioanalytical Laboratory performed testing according to validated analytical methods.
| Bioanalytical Laboratory Activities | Clinical Laboratory Investigations |
|---|---|
|
|
All analytical work followed Good Laboratory Practice (GLP), Standard Operating Procedures (SOPs), and regulatory expectations for bioanalytical method validation.
Packaging
Packaging activities were limited to:
- Receipt of Investigational Products
- Controlled Storage
- Randomization
- Blinding of Study Medication
- Label Verification
- Accountability Documentation
- Dispensing According to Study Protocol
- Secure Return or Destruction of Unused Medication
Biological samples were packaged using validated cold-chain systems with temperature monitoring to preserve sample integrity during storage and shipment.
Applications
The services provided supported pharmaceutical product development and regulatory approvals worldwide. Major applications included:
- Bioavailability (BA) studies
- Bioequivalence (BE) studies
- Phase I clinical trials
- Phase II clinical trials
- Phase III and post-marketing studies
- Pharmacokinetic studies
- Comparative efficacy studies
- Generic drug development
- Regulatory submissions
- Product registration in international markets
- Safety evaluation of new formulations
- Dose optimization studies
The successful execution of approximately 200 BA/BE studies, operation of a 100-bed facility, establishment of a 500-volunteer healthy subject database, and conduct of 132-subject insulin clinical trials demonstrated the capability of the organization to deliver high-quality clinical research compliant with global regulatory expectations.
Planning something similar?
Share your requirement, and we'll help scope what a similar project could look like for you.